Mark T Iwicki's Net Worth

$6.89 Million

Estimate Recalculated Nov 11, 2024 08:47AM EST

Who is Mark T Iwicki?

Mark T Iwicki has an estimated net worth of $6.89 Million. This is based on reported shares across multiple companies, which include Merus N.V., Pulmatrix, Inc., Aerovate Therapeutics, Inc., Akero Therapeutics, Inc., KALA BIO, Inc., Aimmune Therapeutics, Inc., Third Harmonic Bio, Inc., SEPRACOR INC /DE/, and Homology Medicines, Inc..

SEC CIK

Mark T Iwicki's CIK is 0001415537

Past Insider Trading and Trends

2023 was Mark T Iwicki's most active year for acquiring shares with 13 total transactions. Mark T Iwicki's most active month to acquire stocks was the month of April. 2023 was Mark T Iwicki's most active year for disposing of shares, totalling 15 transactions. Mark T Iwicki's most active month to dispose stocks was the month of September. 2007 saw Mark T Iwicki paying a total of $5,724,700.00 for 230,000 shares, this is the most they've acquired in one year. In 2009 Mark T Iwicki cashed out on 249,665 shares for a total of $3,450,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merus N.V. (MRUS) Snapshot price: $50

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
Jun 8
Form 4
∞
73.58K
$7.27
$534,679.12
73.58K
Apr 14
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Jun 30
Form 3
—
0
—
—
0
No matching records found

Pulmatrix, Inc. (PULM) Snapshot price: $2.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Jun 5
Form 4
∞
307K
—
—
307K
Apr 3
Form 4
—
0
—
—
0
Mar 20
Form 4
—
0
—
—
0
Dec 8
Form 3
—
0
—
—
0
No matching records found

Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Apr 2 - Jun 29
Form 3
—
0
—
—
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found

KALA BIO, Inc. (KALA) Snapshot price: $6.1

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.44%
-15.17K
$4.75
-$72,048.00
263.75K
Jun 26
Form 4
-2.58%
-7.39K
$6.09
-$45,017.28
278.92K
May 31
Form 4
+3.53%
9.76K
$6.73
-$30,547.47
286.31K
Jan 4
Form 4
+135.00%
158.87K
—
—
276.55K
Jun 22
Form 4
+156.02%
71.72K
—
—
117.68K
May 31
Form 4
—
0
—
—
0
Mar 14
Form 4
+929.70%
41.5K
$28.54
-$5,650.92
45.97K
Scheduled
Jan 4
Form 4
-11.16%
-561.00
$6.52
-$3,657.72
4.46K
Scheduled
Oct 26
Form 4
-3.08%
-7.97K
$0.37
-$2,950.75
251.18K
Scheduled
Jun 27
Form 4
-3.54%
-9.52K
$1.30
-$12,373.40
259.16K
Scheduled
Jan 3 - Jan 4
Form 4
-9.32%
-27.60K
$1.80
-$49,676.40
268.68K
Scheduled
Oct 26
Form 4
-2.50%
-7.59K
$5.77
-$43,771.22
296.27K
Scheduled
Jun 28
Form 4
+33.35%
76K
—
—
303.86K
Jan 4
Form 4
+359.77%
178.3K
—
—
227.86K
Oct 26
Form 4
∞
49.56K
—
—
49.56K
Jun 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Jul 19
Form 3
—
0
—
—
0
No matching records found